scispace - formally typeset
A

Allan Johansen

Researcher at Odense University Hospital

Publications -  48
Citations -  879

Allan Johansen is an academic researcher from Odense University Hospital. The author has contributed to research in topics: Myocardial perfusion imaging & Coronary artery disease. The author has an hindex of 16, co-authored 48 publications receiving 751 citations. Previous affiliations of Allan Johansen include University of Southern Denmark.

Papers
More filters
Journal ArticleDOI

Left ventricular diastolic function in type 2 diabetes mellitus: prevalence and association with myocardial and vascular disease.

TL;DR: Abnormal LV filling is closely associated with abnormal myocardian perfusion on myocardial perfusion scintigraphy, whereas the association of LV filling with vascular function is less prominent.
Journal ArticleDOI

Prospective Comparison of FFR Derived From Coronary CT Angiography With SPECT Perfusion Imaging in Stable Coronary Artery Disease: The ReASSESS Study.

TL;DR: In patients with stable chest pain and CAD as determined by coronary CTA, the overall diagnostic accuracy levels of FFRCT and SPECT were identical in assessing hemodynamically significant stenosis, however, FFR CT demonstrated a significantly higher diagnostic sensitivity than SPECT.
Journal ArticleDOI

Duration of 18F-FDG avidity in lymph nodes after pandemic H1N1v and seasonal influenza vaccination.

TL;DR: Influenza vaccination may lead to FDG-avid draining lymph nodes beyond 1 month, and Chemotherapy or immunosuppressive drugs given within 2 weeks from vaccination did not affect SUVmax in the axillary lymph nodes.
Journal ArticleDOI

Potential impact of myocardial perfusion scintigraphy as gatekeeper for invasive examination and treatment in patients with stable angina pectoris: observational study without post-test referral bias.

TL;DR: The use of MPS appears to make about half of catheterizations and almost one-fifth of revascularizations redundant and even in high-risk groups, substantial savings are possible, and the risk of overlooking patients with severe disease seems negligible.